Broomfield, CO (PRWEB) March 26, 2009
The American Stem Cell Therapy Association (ASCTA) announced today the online publication of its mission statements and charter. The organization was formed in response to the Food and Drug Administration's (FDA) recent position that the adult stem cells found in everyone's body are drugs, a position the ASCTA opposes. This physician organization is establishing laboratory guidelines that will allow doctors to bring adult stem cell therapy to their patients more quickly. These guidelines will be similar to those used by fertility specialists in In-Vitro Fertilization (IVF) labs, where many of the same cell culture techniques are used.
"Many patients are dying or suffering daily with incurable diseases or problems that require major surgery. These patients should have access to basic adult stem cell therapy now." stated Christopher J. Centeno, M.D, an ASCTA physician member. "ASCTA is establishing guidelines which will allow the safe use of the patient's own adult stem cells under the supervision of doctors." continued Centeno. Another ASCTA physician member, Frank Falco, M.D. stated, "The FDA's position against someone using their own stem cells is taking it too far. We are talking about a person using their own tissue to treat a degenerative disorder or process safely without the use of medications or surgery. Although we agree that oversight and standards are necessary, this should be provided through a physician organization such as ASCTA rather than by a government agency."
Adult stem cells are different than embryonic stem cells. Adult stem cells are found in the patient's body in various tissues. In order to obtain enough stem cells for treatment, they often need to be cultured, similar to today's fertility treatments. Adult stem cells have undergone much more research than embryonic stem cells and therefore are closer to real world treatments. These adult stem cells are taken from the patient's own body (autologous) and ACSTA believes that they are therefore the safest for use in treating patients. "While the Obama administration seems to have opened the embryonic stem cell door, their FDA seems to want to slam the adult stem cell door shut", stated Dr. Centeno.
About the American Stem Cell Therapy Association
The ASCTA is a physician group comprised of various medical and surgical specialties whose goal is to bring safe stem cell therapy to patients by establishing laboratory and clinical guidelines. Christopher J. Centeno, M.D. is a board certified pain management specialist in Colorado who utilizes The Regenexx Procedure, an innovative adult stem cell therapy that helps patients avoid the need for more invasive orthopedic surgery. Dr. Centeno has published numerous medical research papers on the clinical application of adult mesenchymal stem cells. Frank Falco, M.D. is a board certified pain management physician and program director of the Temple University Hospital pain medicine fellowship located in Philadelphia, Pennsylvania who implements minimally invasive techniques for treatment of painful conditions including degenerative spine disorders. For more information, visit http://www.stemcelldocs.org.